UCM176358

Please download to get full document.

View again

of 60
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Information Report
Category:

Documents

Published:

Views: 0 | Pages: 60

Extension: PDF | Download: 0

Share
Related documents
Description
FDA hialuronato de sodio
Tags
Transcript
   U.S. Food and Drug Administration   Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may be outdated.  C-1 Rejena™   (Sodium Hyaluronate   Ophthalmic Solution, 0.18%) United States Food and Drug Administration   Dermatologic and Ophthalmic Drugs Advisory CommitteeJune 26, 2009  C-2 Rejena™   (Sodium Hyaluronate   Ophthalmic Solution, 0.18%)   Safety and Efficacy Review River Plate Biotechnology, Inc.Presenters:   Russell Ellison, MD   Roger Vogel, MD  C-3 Sponsor Attendees  Russell Ellison, MD, MS -Chairman  Luis Molina, PhD -President/CSO  Terry W. Laliberte, BS -Director of Development  Roger Vogel, MD -Medical Monitor, Consultant  Christine Miller, PharmD -Regulatory, Consultant  Gary Koch, PhD -Statistics, Consultant  Steve Crockett, PhD -Statistics, Consultant
Recommended
View more...
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks